Why DYN? Dyne Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
DYN
$17.50+0.11 (+0.63%)
Market OpenUpdated 10:52 AM EDT
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.